FeaturedCustomers names top clinical trial management software vendors in Summer 2026 report

3 hours ago
FeaturedCustomers names top clinical trial management software vendors in Summer 2026 report

By AI, Created 2:56 PM UTC, June 02, 2026, /AGP/ – FeaturedCustomers released its Summer 2026 Clinical Trial Management Software Customer Success Report on June 2, 2026, ranking vendors based on verified customer reference content, market presence and company scores. The report highlights Market Leaders, Top Performers and Rising Stars for buyers evaluating software choices.

Why it matters: - The report is designed to help prospects choose clinical trial management software based on verified customer references instead of vendor marketing. - The rankings give buyers a shortcut to vendors with stronger customer validation, market presence and reference content. - The findings matter to software buyers in a category where reference quality can shape shortlist decisions.

What happened: - FeaturedCustomers published the Summer 2026 Clinical Trial Management Software Customer Success Report on June 2, 2026. - The report ranks vendors in three groups: Market Leaders, Top Performers and Rising Stars. - The release lists the vendors that earned each honor.

The details: - Market Leaders were Advarra, ArisGlobal, IQVIA, Medidata Solutions and Veeva Systems. - Market Leaders are defined as vendors with substantial customer base and market share. - FeaturedCustomers said Market Leaders have the highest ratio of customer reference content, content quality score and social media presence relative to company size. - Top Performers were Castor EDC, CRIO, eClinical Solutions, Ethical GmbH, Florence Healthcare, Greenphire, Medable, Medrio, ObvioHealth, OneStudyTeam, STARLIMS and Viedoc. - Top Performers are described as vendors with significant market presence and enough customer reference content to validate their vision. - FeaturedCustomers said Top Performer products are highly rated by customers but have not reached the customer base and scale of a Market Leader relative to company size. - Rising Stars were CliniOps, Crucial Data Solutions and Ennov. - Rising Stars are vendors with less market presence than Market Leaders or Top Performers but with disruptive technology, growing social presence and enough customer reference content to show momentum. - The report is based on more than 2,000 pieces of verified customer reference content. - A vendor’s overall customer success score uses a weighted average of Content, Market Presence and Company Scores. - Twenty vendors in FeaturedCustomers’ Clinical Trial Management Software category met the minimum requirements for inclusion. - FeaturedCustomers describes itself as a customer reference platform for B2B business software and services. - The company says the platform helps buyers research software through customer testimonials, success stories, case studies and customer videos. - More information is available on FeaturedCustomers’ website.

Between the lines: - The ranking system favors vendors with enough customer proof to support buying decisions, not just product claims. - The three-tier structure suggests a market where scale, reference depth and social visibility still separate established vendors from emerging ones. - Buyers comparing these tools may use the report as a starting filter rather than a final decision tool.

What’s next: - Prospects evaluating clinical trial management software can use the report to narrow vendor lists. - FeaturedCustomers is likely to continue updating its customer success reports as new verified reference content becomes available. - Vendors will likely compete for more customer references and stronger market visibility ahead of future rankings.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

SMB & Me

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Sign up for:

SMB & Me

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.